The landscape of dementia analysis has advanced significantly with the appearance of complex biomarkers, like amyloid PET scans, tau imaging, and blood-primarily based tests which will detect Alzheimer's pathology a long time before indications emerge. While these technological advancements signify extraordinary progress in understanding neurodegenerative conditions, they have not dim... https://rolimj420kwg1.livebloggs.com/profile